Barely Significant
← all excerpts

Efficacy and safety of simultaneous integrated boost intensity-modulated radiotherapy combined with temozolomide for the postoperative chemotherapy treatment of multifocal high-grade glioma.

Front Oncol · 2025 · PMC11973260 · PMID 40196731

1
hedged sentence
closest p
boldest claim

The sentences

showed a trendno p-value reported
A KPS above the median prior to and at the end of RT, respectively, showed a trend towards longer survival in this series, even though statistical evaluations must be considered with caution due to the small number of cases.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.